Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.73 |
| ▸ | HPGD | P15428 | 5/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.59 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.59 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | GGT1 | P19440 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378503 | 1.00 | KDM4E (0.73) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| Benzonitrile SCHEMBL27757506 | 0.88 | KDM4E (0.58) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL8375572 | 0.88 | KDM4E (0.58) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| Bissalicyl Fumarate SCHEMBL13351990 | 0.85 | KDM4E (1.00) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL29805146 | 0.84 | ELANE (0.58) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL17159418 | 0.84 | KDM4E (0.53) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL474832 | 0.84 | ELANE (0.58) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL21314234 | 0.84 | KDM4E (0.53) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL29413361 | 0.84 | THRB (0.56) | KDM4EHSD17B10HPGDMAPTALDH1A1 | |
| SCHEMBL3841280 | 0.84 | THRB (0.56) | KDM4EHSD17B10HPGDMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3890685-B1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | ENCAPSYS LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-12312566-B2 | Compositions comprising benefit agent containing delivery particle | ENCAPSYS, LLC (US) | 2025-05-27 | — | — | US | claimed |
| CN-115300400-B | Transparent, fracture-tough polymeric resins for the production of dental molded bodies | 义获嘉伟瓦登特公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | KULZER GMBH (DE) | 2024-12-26 | — | — | US | claimed |
| US-12146124-B2 | Benefit-agent-containing delivery particles having high core to wall ratios | ENCAPSYS, LLC (US) | 2024-11-19 | — | — | US | claimed |
| CN-112638352-B | Composition comprising benefit agent-containing delivery particles | 恩盖普有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-4312947-A1 | SELF-ADHESIVE FISSURE SEALANT | Kulzer GmbH (DE) | 2024-02-07 | — | — | EP | claimed |
| CN-113164789-B | Composition comprising an encapsulate | 宝洁公司 | 2024-01-09 | — | — | CN | claimed |
| EP-4247895-A1 | POLY ACRYLATE AND POLY(BETA-ESTER) CAPSULES WITH ENHANCED DEGRADABILITY | Encapsys, LLC (US) | 2023-09-27 | — | — | EP | claimed |
| CN-116640061-A | Polymerizable monomer and polymerization method thereof | 阿莱恩技术有限公司 | 2023-08-25 | — | — | CN | claimed |
| US-20220041961-A1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | ENCAPSYS, LLC | 2022-02-10 | — | — | US | claimed |
| EP-3890685-A1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | Encapsys, LLC (US) | 2021-10-13 | — | — | EP | claimed |
| CN-113164789-A | Composition comprising an encapsulate | 宝洁公司 | 2021-07-23 | — | — | CN | claimed |
| CN-112638352-A | Compositions comprising benefit agent-containing delivery particles | 恩盖普有限公司 | 2021-04-09 | — | — | CN | claimed |
| US-20200181543-A1 | COMPOSITIONS COMPRISING ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2020-06-11 | — | — | US | claimed |
| WO-2020117996-A1 | COMPOSITIONS COMPRISING ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-11 | — | — | WO | claimed |
| WO-2020118020-A1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | ENCAPSYS, LLC (US) | 2020-06-11 | — | — | WO | claimed |
| EP-3662974-A1 | COMPOSITIONS COMPRISING ENCAPSULATES | The Procter & Gamble Company (US) | 2020-06-10 | — | — | EP | claimed |
| EP-1187869-B1 | WATER DISPERSIBLE POLYAMIDES WITH ETHYLENICALLY UNSATURATED ENDS | ATOFINA (FR) | 2002-12-04 | — | — | EP | claimed |
| US-6368615-B1 | POLYMER OF UNSATURATED ESTER OF SALICYLIC ACID | GUTTAG ALVIN (US) | 2002-04-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041961-A1 | COMPOSITIONS COMPRISING BENEFIT AGENT CONTAINING DELIVERY PARTICLE | APOB, CHMP4B, HDLBP | KDM4E 4576/4885HSD17B10 1894/4885HPGD 2991/4885 |
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | ESD, GFER, FUS | KDM4E 2920/4885HSD17B10 1806/4885HPGD 819/4885 |
| US-12312566-B2 | Compositions comprising benefit agent containing delivery particle | APOB, CHMP4B, HDLBP | KDM4E 4576/4885HSD17B10 1894/4885HPGD 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.